Financials
- Market Capitalization 586.53 M
- Employee 353
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-8.31
売上高対価格比率
1.44
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2765 | AQST Aquestive Therapeutics, Inc. - Common Stock | 5.16 USD | -4.27% | +13.66% | +37.97% | +34.73% | 647.64 M USD | ||
| 2791 | TLRY Tilray Brands, Inc. - Common Stock | 4.57 USD | -1.51% | -2.97% | +13.40% | +217.36% | 622.45 M USD | ||
| 2958 | KMDA Kamada Ltd. - Ordinary Shares | 8.26 USD | -1.43% | +2.99% | +17.33% | +17.83% | 476.49 M USD | ||
| 2977 | BIOA BioAge Labs, Inc. - Common Stock | 10.08 USD | +2.44% | +3.07% | -54.10% | +32.63% | 462.64 M USD |